Clinical trials
Epistaxis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
88 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 6 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 46 |
| Unknown status | 16 |
| Not yet recruiting | 7 |
| Terminated | 7 |
| Recruiting | 6 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 5 |
| Bezmialem Vakif University | 3 |
| Cure HHT | 3 |
| University of Zurich | 3 |
| Ajou University School of Medicine | 2 |
| Hospices Civils de Lyon | 2 |
| Imperial College London | 2 |
| Unity Health Toronto | 2 |
| University of California, San Diego | 2 |
| Ain Shams University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epistaxis | 88 |
| Telangiectasia, Hereditary Hemorrhagic | 30 |
| Anemia | 3 |
| Nasal Obstruction | 3 |
| Airway Obstruction | 2 |
| Arteriovenous Malformations | 2 |
| Bronchial Spasm | 2 |
| Gastrointestinal Hemorrhage | 2 |
| Hemorrhage | 2 |
| Pain | 2 |
Trials
Showing 1 to 25 of 88. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.